血管內(nèi)皮生長因子121(VEGF121)活性蛋白
Active Vascular Endothelial Growth Factor 121 (VEGF121)
- 編號APB851Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 97%
- 等電點6.3
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1728 ¥ 4320 ¥ 8640 ¥ 25920 ¥ 64800
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
VEGFA (Vascular endothelial growth factor A) is a growth factor and can be cleaved into several isoforms, including VEGF121. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. It is accepted that the VEGF121 isoform stimulates the proliferation of vein endothelial cells. Thus, proliferation assay of recombinant human VEGF121 was conducted using ECV-304 cells. Briefly, ECV-304 cells were seeded into triplicate wells of 96-well plates at a density of 2,000 cells/well and allowed to attach overnight, then the medium was replaced with serum-free standard 1640?prior to the addition of various concentrations of VEGF121. After incubated for 48h,?cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10μL of CCK-8 solution was added to each well of the plate, then the absorbance at 450nm was measured using a microplate reader after incubating the plate for 1-4 hours at 37°C. Proliferation of ECV-304 cells after incubation with VEGF121 for 48h observed by inverted microscope was shown in Figure 1. Cell viability was assessed by CCK-8 (Cell Counting Kit-8 ) assay after incubation with human recombinant VEGF121 for 48h. The result was shown in Figure 2. It was obvious that VEGF121 significantly increased cell viability of ECV-304 cells.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB851Hu01 | 血管內(nèi)皮生長因子121(VEGF121)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB851Hu02 | 血管內(nèi)皮生長因子121(VEGF121)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB851Hu01 | 血管內(nèi)皮生長因子121(VEGF121)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB851Hu01 | 血管內(nèi)皮生長因子121(VEGF121)多克隆抗體 | WB; IHC; ICC; IP. |
PAB851Hu02 | 血管內(nèi)皮生長因子121(VEGF121)多克隆抗體 | WB; IHC; ICC; IP. |
LAB851Hu71 | 血管內(nèi)皮生長因子121(VEGF121)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB851Hu22 | 血管內(nèi)皮生長因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu23 | 血管內(nèi)皮生長因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu24 | 血管內(nèi)皮生長因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu25 | 血管內(nèi)皮生長因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu27 | 血管內(nèi)皮生長因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu21 | 血管內(nèi)皮生長因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
SEB851Hu | 血管內(nèi)皮生長因子121(VEGF121)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB851Hu | 血管內(nèi)皮生長因子121(VEGF121)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
PSB851Hu01 | 血管內(nèi)皮生長因子121(VEGF121)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSB851Hu01 | 血管內(nèi)皮生長因子121(VEGF121)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Oncogene | Elevated PLGF contributes to small-cell lung cancer brain metastasis [PubMed: 22797069] |
BMC?Cancer | VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma [Pubmed:29747600] |
JOURNAL OF CLINICAL NEUROSCIENCE | A pediatric case of anaplastic astrocytoma with a gliomatosis cerebri; the growth pattern and changes in serum VEGF-121 levels after bevacizumab treatment [Pubmed: 33222957] |
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE | Associations between VEGF isoforms and impending retinopathy of prematurity [Pubmed: 32737903] |
international journal of oncology | Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma [Pubmed: 32377747] |